Research Priorities

Pipeline Overview

We have a total of 8 assets across four business programs, which include two development programs in pre-clinical stage, three programs in clinical phase 1, two in clinical phase 2, and one in clinical phase 3.

Expanded Access Policy

To support our mission, we are focused on enrolling and conducting the clinical trials necessary to gain regulatory approvals to make our interventions broadly available as quickly as possible, and we are privileged to collaborate with our development partners, clinical trial investigators, community advisory boards, and with participants in our clinical trials supporting our development programs. The Gates MRI is focused on evaluating investigational products in clinical trials and does not have an expanded access program for investigational products. Information about Gates MRI-sponsored clinical trials can be found on our website and on clinical trial registries, e.g., https://clinicaltrials.gov/ under trials listed for Gates Medical Research Institute.